| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |